[PDF][PDF] Evaluation of clinical characteristics and knowledge in inflammatory bowel disease patients
GS Prabha, N Srinivasan, KTM Kumar… - Journal of Evolution of …, 2021 - researchgate.net
BACKGROUND Chronic conditions of Ulcerative Colitis and Crohn's Disease with unknown
aetiology and relapse were collectively known as inflammatory bowel disease (IBD). The …
aetiology and relapse were collectively known as inflammatory bowel disease (IBD). The …
[HTML][HTML] Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
T Kobayashi, T Hisamatsu, Y Suzuki… - Intestinal …, 2018 - synapse.koreamed.org
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing …
(UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing …
[PDF][PDF] High prevalence of untreated and undertreated vitamin d deficiency and insufficiency in patients with inflammatory bowel disease
Inflammatory bowel disease (IBD) patients with vitamin D deficiency show an increased risk
of hospital admission, surgery, and loss of response to biologic therapy while high vitamin D …
of hospital admission, surgery, and loss of response to biologic therapy while high vitamin D …
[HTML][HTML] The Effects of Acupuncture on Crohn's Disease: a systematic review and meta-analysis
JH Bae, SY Kang, SE You, HI Jeong… - Journal of …, 2023 - ncbi.nlm.nih.gov
Objectives Crohn's disease is a chronic gastrointestinal disease that belongs to
inflammatory bowel disease. This systematic review aims to assess the level of evidence in …
inflammatory bowel disease. This systematic review aims to assess the level of evidence in …
[HTML][HTML] The efficacy of infliximab combined with surgical treatment of fistulizing perianal Crohn's disease: Comparative analysis according to fistula subtypes
Summary Background/Objective Infliximab is regarded as an effective therapeutic to treat
Crohn's disease. This study aimed to assess the efficacy of infliximab combined with surgery …
Crohn's disease. This study aimed to assess the efficacy of infliximab combined with surgery …
[HTML][HTML] Efficacy of adalimumab in Korean patients with Crohn's disease
IW Sohn, ST Kim, B Kim, HJ Lee, SJ Park, SP Hong… - Gut and liver, 2016 - ncbi.nlm.nih.gov
Methods We retrospectively reviewed 62 patients with CD who were treated with
adalimumab. Their Crohn's disease activity index (CDAI) was measured at weeks 4, 8, and …
adalimumab. Their Crohn's disease activity index (CDAI) was measured at weeks 4, 8, and …
[HTML][HTML] 老年起病克罗恩病的临床特点及远期预后
魏青林, 李文, 金鹏, 盛剑秋, 李世荣… - Journal of Central South …, 2023 - ncbi.nlm.nih.gov
老年起病克罗恩病的临床特点及远期预后- PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis
J Zeng, Z Wang, XJ Yang - European Journal of Clinical Pharmacology, 2022 - Springer
Background The placebo effect in randomized controlled trials (RCTs) for East Asian
patients with ulcerative colitis (UC) has been poorly characterized. This systematic review …
patients with ulcerative colitis (UC) has been poorly characterized. This systematic review …
Longitudinal trends in direct costs and healthcare utilization ascribable to inflammatory bowel disease in the biologic era: a nationwide, population‐based study
EY Park, DH Baek, GH Kim, C Kim… - Journal of …, 2023 - Wiley Online Library
Abstract Background and Aim Biologic‐era data regarding the direct cost and healthcare
utilization of inflammatory bowel disease at the population level are limited, especially in …
utilization of inflammatory bowel disease at the population level are limited, especially in …
Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease‐Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal …
X Wu, H Liu, X Shi, W Zhou, Z Jiang… - Gastroenterology …, 2018 - Wiley Online Library
Background. The aim of this study was to evaluate the interobserver variability in diagnosing
inflammatory bowel disease (IBD)‐associated neoplasia among practicing pathologists from …
inflammatory bowel disease (IBD)‐associated neoplasia among practicing pathologists from …